Periostin in ovarian carcinoma: from heterogeneity to prognostic value.
Ludmila LozneanuIrina Draga CăruntuCornelia AmalineiMihaela MoscaluBogdan GaftonMihai Vasile MarincaAndreea RusuRaluca BalanSimona Eliza GiușcăPublished in: Folia histochemica et cytobiologica (2023)
The comparative assessment of POSTN immunoexpression in two tumor compartments: in tumor cells and stroma, by use of different scoring systems revealed that higher stromal POSTN levels are evidently correlated with unfavorable clinical features and poorer prognosis, while POSTN expression in tumor cells seems to be associated with a better patient outcome.